Purpose: Recently, focal adenomyosis was classified into three subtypes according to magnetic resonance imaging findings: connected to the endometrium (subtype I), connected to the perimetrium (subtype II), and not connected to either the endometrium or the perimetrium (subtype III). However, diffuse adenomyosis and cystic adenomyosis have not been investigated. We attempted to classify diffuse-type adenomyosis and cystic-type adenomyosis according to magnetic resonance imaging findings and verified the validity of the previous classification of focal adenomyosis. Methods: A total of 1504 cases of adenomyosis (focal, n = 1093; nodular, n = 15; diffuse, n = 383; cystic, n = 13) shown in magnetic resonance imaging findings of patients who underwent conservative surgical treatment from 2002 to 2016 at our hospital were reviewed according to the criteria of Kishi. Results: Of the 383 patients with diffuse adenomyosis, 272 (70.8%) were classified as subtype I, while all cases of cystictype adenomyosis developed in the lateral wall of the uterus were classified as subtype III. Conclusion: Our findings indicate that diffuse adenomyosis develops from the same mechanism as focal adenomyosis subtype I. In addition, we consider that subtype III has greater relationship with cystic adenomyosis than the other types.
Introduction
Since the condition was first reported by Cullen 1 in 1908, uterine adenomyosis has been considered to arise from an invasion of normal endometrium into the myometrium. Recently, Kishi et al. 2 showed that adenomyosis can be differentiated into three subtypes according to magnetic resonance imaging (MRI) findings: connected to the endometrium (subtype I), connected to the perimetrium (subtype II), and not connected to either the endometrium or the perimetrium (subtype III). They also suggested that subtype I develops from endometrium as described by Cullen, whereas subtype II develops from endometriosis and subtype III from metaplastic changes of the Mullerian system. This classification is very important, as they are different from previously held notions regarding the histogenesis of adenomyosis. However, diffuse-type and cystic-type adenomyosis were not included in their study. Here, we investigated patients with diffuse adenomyosis and cystic adenomyosis who were treated at our hospital and attempted to classify those cases according to the definitions of Kishi et al. and also verify the validity of their findings.
Methods
During the 14-year period from 2002 to 2016, a total of 1559 patients underwent conservative surgical treatment for pathologically diagnosed uterine adenomyosis at our hospital. During that period, all cases were diagnosed based on findings from preoperative MRI. MRI findings were available for 1504 patients and those were reviewed in this study. Diagnoses were made based on sagittal and transverse T2-weighted images. Although uterine adenomyosis was classified according to the definition of Kishi et al., cases in which adenomyosis lesions showed invasion throughout the uterine wall were classified as entirely invasive. Endometriosis and adenomyosis were diagnosed from histopathological examination results. Patient statements on history of pregnancy were accepted.
With the advent of conservative surgery at our hospital, we have divided adenomyosis into focal, nodular, cystic, and diffuse types according to the development form in order to choose the proper surgical method. 3 Focal type is differentiated into anterior, posterior, lateral, and fundal wall adenomyosis, which occupies certain parts of the uterine muscle. On the other hand, diffuse type is defined as adenomyosis occupying both anterior and posterior walls and is connected to each other ( Figure 1 ). Adenomyosis lesions that were round and clearly demarcated from surrounding normal muscle were designated as nodular type. Lesions containing bloody fluid in the center of the focus were designated as the cystic type (Figure 2 ). When the adenomyosis lesions were divided into two or more parts, the largest part was considered to be representative. Forms and sites of development were also compared between the nodular and cystic types. Endometriosis was defined when endometrial tissue was revealed pathologically at a site other than the uterine cavity, and most of those cases were classified as ovarian chocolate cyst.
Obstetric history was divided into nulligravid and multigravid. Statistical analysis was performed using a chisquare test and Mann-Whitney U test. The study protocol received local institutional board approval.
Results
Subtypes I, II, and III were seen in 618, 520, and 21 cases, respectively, while entirely invasive were seen in 345 (Table 1) . When the location of adenomyosis was divided according to the six types (i.e. anterior, posterior, diffuse, nodular, cystic, and other), subtype I was seen to develop at every site, including the anterior wall in 27.5%, posterior wall in 26.5%, and diffuse type in 43.9%. Conversely, most cases of subtype II developed in the posterior wall (anterior wall in 4.8%, posterior wall in 91.7%, and diffuse type in 0.6%). Subtype III mainly developed in cystic adenomyosis, such as in the anterior wall in 4.8%, posterior wall in 23.8%, nodular type in 9.5%, and cystic type in 61.9% (Table 1) .
When these results were evaluated from the perspective of the location of a developing adenomyosis, that in the anterior wall consisted of subtype I in 65.4% (170/260), and adenomyosis developing in the posterior wall was subtype II in 59.3% (477/804), while diffuse type consisted of subtype I in 70.8% (271/383), and cystic type consisted of subtype III in all cases (Table 1) .
In a comparison of nodular and cystic adenomyosis, the focus was solitary in 15 of 16 cases of cystic-type adenomyosis. On the other hand, solitary developing nodular adenomyosis occurred in 15 patients, whereas nodular adenomyosis coexisting with other types of adenomyosis was found in 25. Moreover, though nodular adenomyosis was found to develop mainly in the anterior or posterior wall, all cases of cystic adenomyosis showed a location in the uterine lateral wall. Mean age was significantly younger in cystic-type adenomyosis than nodular-type adenomyosis cases (Table 2) .
Coexisting endometriosis was seen in 10.2% of subtype I, 63.5% of subtype II, and 14.3% of subtype III, thus was significantly more frequent in the subtype II cases. A 
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history of pregnancy was seen in 66.2% of subtype I, 29.0% of subtype II, and 23.8% of subtype III patients, with a significantly higher frequency of pregnancy in subtype I. No significant difference in age distribution was evident between subtypes I and II, with mean ages of 38.5 and 37.3 years, respectively.
Discussion
Adenomyosis subtype I is considered to develop from deep muscle invasion of the normal endometrium, as proposed by Cullen. This type is most often seen in parous women and developed evenly among the anterior-posterior walls, with diffuse findings noted in this study. These characteristics suggest that the development of subtype I is markedly influenced by past pregnancy, with every part of the uterus evenly effected. However, one-third of the patients in our study with this type were nulligravid, thus a history of pregnancy is not the only reason for its development.
We also found that 70% of patients with subtype II were nulligravid and most of those cases arose from the epithelium of the posterior surface of the uterus and were coexistent with endometriosis. These results support the notion that subtype II adenomyosis arises from pelvic endometriosis, as suggested by Kishi et al. Although the focus in cases of subtype I adenomyosis can develop anywhere in the uterus, subtype II adenomyosis lesions are mainly seen in the posterior wall, resulting in posterior adenomyosis becoming the most common type.
Subtype III in the classification of Kishi et al. does not connect to the surface epithelium or endometrium, and such cases were rare in our study. Those patients were treated as relatively advanced cases, as the lesions may have already invaded to the surface epithelium or endometrium.
According to our differentiation method, we consider that subtype III is nodular adenomyosis. However, our subtype III adenomyosis cases showed focal, nodular, and cystic types. In particular, all cases of cystic-type adenomyosis, which were not included in the report of Kishi et al., were classified as subtype III adenomyosis in our analysis.
Nodular adenomyosis coexistent with other types of adenomyosis was more frequent than solitary nodular adenomyosis. Conversely, even though adenomyosis generally arises along the midline of the uterus, most This phenomenon may suggest that nodular adenomyosis not only arises de novo but also from the same mechanisms related to focal adenomyosis. Therefore, we speculate that cystic type is more likely to appear as subtype III adenomyosis. In summary, the classification system that divides adenomyosis into three subtypes, with subtype I developing from the endometrium and subtype II developing from surface serosa, is convincing. Diffuse adenomyosis seems likely to develop from the same mechanisms as subtype I. We also agree that subtype III is a de novo product (i.e. a product of the metaplasia of pluripotential immature cells of Mullerian origin that become misplaced into the myometrium) as suggested by Kishi et al., though we think that this subtype has a stronger relationship with cystic adenomyosis than nodular adenomyosis based on the present findings. Additional investigations are needed.
